Navigation Links
Finding the right mix: A biomaterial blend library

From dental implants to hip replacements, biomaterials have become big business. But scientists pursuing this modern medical revolution share a basic challenge: biocompatibility. How will a biomaterial on the lab bench actually work inside the human body? Will a patient accept the new material or suffer an inflammatory response? And can that material survive in a human's complex system?

To tackle such questions, researchers at the National Institute of Standards and Technology (NIST) and the New Jersey Center for Biomaterials (NJCB) at Rutgers University have developed new methods to analyze the interactions between cells and biomaterials. Their work could lead to inexpensive techniques for building better biomaterials.

Polymers derived from the amino acid tyrosine make up a broad class of degradable biomaterials under investigation. Such materials provide a temporary scaffold for cells to grow and tissue to regenerate. In a 2006 study* presented at the national meeting of the American Chemical Society in September, the researchers analyzed how two types of model cells--immune cells known as macrophages and bone cells known as osteoblasts--responded to changes in the composition of thin films made of these tyrosine-derived polymers. In practice, many biomaterials are made from blends of polymers to achieve specific material properties. Optimizing the blend composition is often a difficult and time-consuming task. As the blends gained a higher or lower proportion of a respective material, the cells around them react by changing shape, ultimately increasing or decreasing contact with the films. In the body, such cell-material dynamics are critically important to the outcome--determining whether a biomaterial leads to inflammation or abnormal cell growth, for example.

The new study represents an innovative line of research. Working with NJCB, NIST scientists have developed a method for constructing "scaffold libraries" --collections of bioma
'"/>

Source:National Institute of Standards and Technology (NIST)


Page: 1 2

Related biology news :

1. Finding Cures For Tropical Diseases: Is Open Source An Answer?
2. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
3. Findings have implications for tracking disease, drugs at the molecular level
4. Finding hidden invaders in a Hawaiian rain forest
5. New Finding May Aid Adult Stem Cell Collection
6. Finding rewrites the evolutionary history of the origin of potatoes
7. Finding the minds eye
8. Findings advance use of adult stem cells for replacement bone
9. Finding a virus is not all bad news
10. Finding a better way to make biodiesel
11. Finding paves way for better treatment of autoimmune disease

Post Your Comments:
(Date:11/24/2009)...search on bacterial communities throughout six lar...poral patterns, suggesting that scientists could u...mate change in the polar regions. The study, publi... Academy of Sciences Early Edition, shows that ba...hronously over time, correlating with seasonal shi...
(Date:11/23/2009)...dence that the "synergistic" effect of early-life ... and indoor endotoxin causes more harm to developi..., Environmental health scientists at the Universi...wn that children exposed to both high levels of tr...g early life are six times more likely to experien...
(Date:11/23/2009)...pplied mathematicians dissected the morphology of ...ristic long leaf with a saddle-like arc midsection...imple cause of the lily,s fan-like shapeelastic re...l growthwas revealed by using an equally simple te... a postdoctoral student at Harvard,s School of Eng...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2The cause behind the characteristic shape of a long leaf revealed 2Obama Administration Advances Long Term Services and Supports in Health Care Reform 50938 1Obama Administration Advances Long Term Services and Supports in Health Care Reform 50938 2ICSI Plans Symposium on New Depression Treatment Program That Is Improving Patient Outcomes Five Fold Over Typical Primary Care 50936 1ICSI Plans Symposium on New Depression Treatment Program That Is Improving Patient Outcomes Five Fold Over Typical Primary Care 50936 2Genes Linked to Cholesterol in Cells Are Identified 50935 1Genes Linked to Cholesterol in Cells Are Identified 50935 2
...sh are no strangers to Americans. From the comedic...hildren,s Disney favorite, "Nemo," fish can talk, ...he silver screen. But can real fish verbally commu...ed in the July 18 issue of the journal Science . ... communications of all vertebrates--in evolutionar...
...HI A new indicator of coral health has been disco...algae called dinoflagellates. The study, released ...s of the National Academy of Sciences, reveals th... more susceptible to disease. , "Corals are fasc...inoflagellates that live inside the coral,s tissue...
... way from the dull hums of the amorous midshipman ...ven to the simplest Celine Dion melody. But the ne...t to mention birdsongs, frog thrums and mating cal...own hundreds of millions of years ago with the hum...e developing brain cells in newly hatched midshipm...
Other Biology News:New indicator uncovered that can predict coral health 2New indicator uncovered that can predict coral health 3From humming fish to Puccini: Vocal communication evolved with ancient species 2
(Date:11/24/2009)... , REYKJAVIK, Iceland, Novemb...nc. (Nasdaq: DCGN ) today announced the approval o...uptcy Court for the District of Delaware,(the "Ban...y petition for,relief under Chapter 11 of the Unit...t. , The orders issued by the Bankruptcy ...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia...Food & Drug Administration (SFDA) has approved...r its oral insulin project,(Nodlin), an innovative...pproval allows Biolaxy to initiate its first phase...er characteristic of high blood glucose and poor,m...
(Date:11/24/2009)... , , Primary efficacy endpoint has been me...t endometrial cancer, , QUEBEC CITY, Nov. 24 ...SDAQ: AEZS ; TSX: AEZ) (the "Company"), a global ...rapy and oncology, today announced positive effica...otoxic peptide conjugate, AEZS-108 (formerly AN-15...
(Date:11/24/2009)... , SAN DIEGO, Nov. 24, 2009 /PRNewswire-Fi...ARNA ) announced today that the company is sched...ealth Care Conference on December 1, 2009 at 11:30... New York Palace Hotel in New York City. Jack Lief...s scheduled to provide an overview of the company,...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...ion of,North America and its partner Helsinn Healt...ug Administration (FDA) has approved a new oral,fo... for the prevention of,chemotherapy-induced nausea...al administration is indicated for the prevention ... repeat courses of moderately emetogenic,chemother...
...-- WuXi PharmaTech (NYSE:,WX), a leading pharmaceu...nd development outsourcing company with operations...hat it has promoted Dr. Rujian Ma to Vice,Presiden...scom.com/cgi-bin/prnh/20040705/CNM002LOGO ), Dr.... Scientific,Officer of WuXi PharmaTech., "I am ve...
...e-FirstCall/ - OncoGenex,Pharmaceuticals (NASDAQ: ...s,custirsen sodium, received Fast Track designatio...n combination with docetaxel for progressive,metas...ting five Phase 2,clinical studies in prostate, lu...he production of a specific protein, clusterin, as...
Other Biology Technology:FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting 2FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting 3WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry 2FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011 2FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011 3FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011 4
...product has been developed to significantly increa...oteins. Stability is increased at room temperatur.... This product is subjected to 0.2 micron filtrat...lation insures consistently high levels of activit...
Corning brand cover glass squares, 0.16 to 0.19mm thick from Sigma-Aldrich
...uropean Collection of Cell Cultures (ECACC) has be...y, academia and government institutes for over sev...troduce candidates to cell culture and a Level II ... as planning and management of a cell culture labo...
DU 530 Life Science UV/Visible Spectrophotometers from Beckman Coulter
Biology Products: